expo marcadires tumorales (2)

Upload: bridgitparrales

Post on 24-Feb-2018

220 views

Category:

Documents


0 download

TRANSCRIPT

  • 7/25/2019 Expo Marcadires Tumorales (2)

    1/23

    UNIVERSIDAD NACIONAL DE CHIMBORAZO

    FALCULTAD DE CIENCIAS DE LA SALUD

    ESCUELA DE LABORATORIO CLNICO E

    HISTOPATOLGICO

    CATEDRA DE:

    TCNICAS HISTOLGICAS

    DOCENTE:

    LIC. IVN PEAFIEL

    GRUPO: N3 DE RECUPERACION

    TERCER SEMESTRE

    PERIODO ACADMICO: OCTUBRE 2015- FEBRERO 2016

    RIOBAMBA ECUADOR

    GRUPO N-3 de e!"#e$!%&'

  • 7/25/2019 Expo Marcadires Tumorales (2)

    2/23

    (PRUEBAS DE MARCADORES TUMORALES TCNICASHISTOLGICAS)

    INTEGRANTES:

    N- APELLIDOS * NOMBRES+ Are!"#$ %&''e(")e, *$r+,)e I)$ N$+$(/ V""$)$3 Ne *&re34) A)$ L!"$ R$,re P$rr$(e' !r(e)7" Br"88"+e

    TEMA:

    P"e.$/ de 0$!$d1e/ 2"01$e/ 24!'%!$/ 5%/21&6%!$/

    PARTICIPACINN9- 25: 50: ;5: 100: O$er ($")e'+"8$"4)

    2 100: N& >!

  • 7/25/2019 Expo Marcadires Tumorales (2)

    3/23

    (PRUEBAS DE MARCADORES TUMORALES TCNICASHISTOLGICAS)

    )er. E'+&' $r$7&re' 'e #!e7e) e)&)+r$r e) 7"er'&' '"+"&' 7e )!e'+r&

    &r8$)"'&. A(8!)&' 'e e)!e)+r$) e) ($ &r")$ ! &+r&' @(!"7&' &r#&r$(e'. O+r&' e) (&'

    +!&re' / &+r&' +e3"7&'. A ee' '&) #r&7!+&' 7e ($' "'$' (!($' $)er&'$' &

    '&) #r&7!"7&' #&r e( !er#& e) re'#!e'+$ $( )er.

    L&' $r$7&re' +!&r$(e' '&) !)$ 'er"e 7e '!'+$)"$' !e #!e7e) 7e+e+$r'e

    7e#e)7"e)7& 7e( +"#& 7e $r$7&r e) '$)8re &r")$ >ee' ! &+r&' +e3"7&' 7e(

    &r8$)"'& / !/$ #re'e)"$ e) !)$ &)e)+r$"4) '!#er"&r $ 7e+er")$7& )"e( #!e7e

    ")7"$r ($ e"'+e)"$ 7e !) )er.

    Se 7e

  • 7/25/2019 Expo Marcadires Tumorales (2)

    4/23

    (PRUEBAS DE MARCADORES TUMORALES TCNICASHISTOLGICAS)

    OBETIVO GENERAL

    C&)&er (&' 7"@ere)+e' $r$7&re' +!&r$(e' / $'&"$r(&' &) ($ +e#r$)$ 7e+e"4)

    e) !)$ #er'&)$ &) )er $ +r$' 7e !)$ re"'"4)

  • 7/25/2019 Expo Marcadires Tumorales (2)

    5/23

    (PRUEBAS DE MARCADORES TUMORALES TCNICASHISTOLGICAS)

    L&' $r$7&re' +!&r$(e' '&) !)$ 'er"e 7e '!'+$)"$' !e #!e7e) 7e+e+$r'e

    7e#e)7"e)7& 7e( +"#& 7e $r$7&r e) '$)8re &r")$ >ee' ! &+r&' +e3"7&' 7e(

    &r8$)"'& / !/$ #re'e)"$ e) !)$ &)e)+r$"4) '!#er"&r $ 7e+er")$7& )"e( #!e7e

    ")7"$r ($ e"'+e)"$ 7e !) )er. A!)!e !)$ &)e)+r$"4) $)&r$( 7e !) $r$7&r+!&r$( #!e7$ '!8er"r ($ #re'e)"$ 7e )er e'+& #&r ', "'& )& e' '!@""e)+e #$r$

    7"$8)&'+"$r(&. Ge)er$(e)+e '! !+"("7$7 'e re7!e $ '&'#e>$r e( 7"$8)4'+"& &

    $(&r$r ($ e&(!"4) 7e !) +!&r 7e+e+$7& #&r &+r&' #r&e7""e)+&'. L$ $/&r #$r+e

    7e (&' $r$7&re' +!&r$(e' #!e7e) 'er #r&7!"7&' +$

  • 7/25/2019 Expo Marcadires Tumorales (2)

    6/23

    (PRUEBAS DE MARCADORES TUMORALES TCNICASHISTOLGICAS)

    ?. S! &)e)+r$"4) e) '$)8re ! &+r&' @(!"7&' &r#&r$(e' 7e @"( $e'& 7e

    )& !#(e) (&' re!"'"+&' 7e !) $r$7&r +!&r$( "7e$( ")(!'& !>&' 7e e((&' 'e

    e) $(+er$7&' e) #r&e'&'

  • 7/25/2019 Expo Marcadires Tumorales (2)

    7/23

    (PRUEBAS DE MARCADORES TUMORALES TCNICASHISTOLGICAS)

    MARCADORES TUMORALES CON SENSIBILIDAD VARIABLE * BAA

    ESPECIFICACIDAD: S&) $!e((&' !/$ 'e)'"$'+$ '! ($'"@"$"4) ($ $)+er"&r >$,$ re@ere)"$ && >e&' 7">& $

    ($ 'e)'""7r$+$7&' JCA 15. CA 1Q.Q CA 125 CA ;2.? CFRA

    21.1K / $)+,8e)& #r&'++"& e'#e,@"& JPSAK.

    ENZIMAS: C&& ($ NSE Je)&($'$ )e!r&)$( e'#e,@"$K / L=H J(+"&

    7e'>"7r&8e)$'$K.

    GRUPO 7e re!#er$"4) D *ARCA=ORES TU*ORALES 7

  • 7/25/2019 Expo Marcadires Tumorales (2)

    8/23

    (PRUEBAS DE MARCADORES TUMORALES TCNICASHISTOLGICAS)

    OTROS MARCADORES:A)+"!er#&' @re)+e $ &)r&+e,)$' J#5K #r&+e,)$'

    'r"$' J-2 "r&8(&,8$7&/ +!&re' 7e (!($' 8er")$+"$'

    Te3"7& $)$("$7& S$)8re

    C4& 'e !'4 P$r$ $/!7$r $ 7"$8)&'+"$r)er 7e >,8$7& / "8"($r($

    re$"4) $( +r$+$"e)+& #$r$ e$(!$r e( e'+$7"& e(#r&)4'+"&/ ($ re$"4) $(

    +r$+$"e)+& 7e +!&re' 7e (!($' 8er")$+"$'

    A)("'"' 7e !+$"4)7e(8e)EGFR

    T"#& 7e )erC)er 7e #!(4) 7e (!($' )& #e!e$'

    Te3"7& $)$("$7& T!&r

    C4& 'e !'4 P$r$ $/!7$r $ 7e+er")$r e( +r$+$"e)+& / e( #r&)4'+"&

    A)("'"' 7e !+$"4) 7e( 8e) KRAS

    T"#&' 7e )er C)er &(&rre+$(/ )er 7e #!(4) 7e (!($' )&

    #e!e$'

    GRUPO 7e re!#er$"4) D *ARCA=ORES TU*ORALES 8

    http://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000658873&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000044242&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000044242&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045695&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000270735&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000046450&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000454803&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000454803&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045885&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045885&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045849&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000046063&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045693&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045693&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045323&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045323&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000444983&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000444983&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000658873&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000044242&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045695&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000270735&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000046450&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000454803&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045885&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045849&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000046063&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045693&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045323&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000444983&version=Patient&language=Spanish
  • 7/25/2019 Expo Marcadires Tumorales (2)

    9/23

    (PRUEBAS DE MARCADORES TUMORALES TCNICASHISTOLGICAS)

    Te3"7& $)$("$7& T!&r

    C4& 'e !'4 P$r$ 7e+er")$r '" e( +r$+$"e)+& &) !) +"#& e'#e,@"&

    7e +er$#"$ 7"r"8"7$e' $#r"$7&

    A)+,8e)& $r")&e$ re8re'$7&

    A)+,8e)& #r&'++"& e'#e,@"&JPSAK

    T"#& 7e )erC)er 7e #r4'+$+$

    Te3"7& $)$("$7& S$)8re

    C4& 'e !'4 P$r$ $/!7$r e) e( 7"$8)4'+"& e$(!$r ($ re$"4) $( +r$+$"e)+&

    /

    CA15-CA2;.2Q

    T"#& 7e )er C)er 7e 'e)&

    Te3"7& $)$("$7& S$)8re

    GRUPO 7e re!#er$"4) D *ARCA=ORES TU*ORALES 9

    http://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000270742&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000357558&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000046540&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000445079&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000445079&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000046450&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045861&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000737144&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000044998&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045135&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045135&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000270742&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000357558&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000046540&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000445079&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000046450&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045861&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000737144&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000044998&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045135&version=Patient&language=Spanish
  • 7/25/2019 Expo Marcadires Tumorales (2)

    10/23

    (PRUEBAS DE MARCADORES TUMORALES TCNICASHISTOLGICAS)

    C4& 'e !'4 P$r$ e$(!$r '" e( +r$+$"e)+& e'+ @!)"&)$)7& & '" ($

    e)@ere7$7 >$ re8re'$7&

    CA1Q-Q

    T"#&' 7e )erC)er 7e #)re$' )er 7e e',!($

  • 7/25/2019 Expo Marcadires Tumorales (2)

    11/23

    (PRUEBAS DE MARCADORES TUMORALES TCNICASHISTOLGICAS)

    C4& 'e !'4 P$r$ 7e+er")$r '" e( +r$+$"e)+& &) !)$ +er$#"$ 7"r"8"7$ e' e(

    $7e!$7&

    C(!($' +!&r$(e' "r!($)+e' 7e &r"8e) e#"+e("$(JCELLSEARCHK

    T"#&' 7e )er C)ere' e+$'++"&' 7e 'e)& 7e#r4'+$+$/ &(&rre+$(

    Te3"7& $)$("$7& S$)8re

    C4& 'e !'4 P$r$ 7$r @&r$ $ ($ +&$ 7e 7e"'"&)e' 7"$' / #$r$ e$(!$r

    e( #r&)4'+"&

    Cr&&8r$)")$ AJC8AK

    T"#& 7e )erT!&re' )e!r&e)7&r")&'

    Te3"7& $)$("$7& S$)8re

    C4& 'e !'4 P$r$ $/!7$r e) e( 7"$8)4'+"& e) ($ e$(!$"4) 7e ($ re$"4) $(

    +r$+$"e)+& / e) ($ e$(!$"4) 7e ($ re"7"$

    Cr&&'&$' ; 1; / Q#21

    T"#& 7e )erC)er 7e e3"8$

    Te3"7& $)$("$7& Or")$

    C4& 'e !'4 P$r$ $/!7$r e) ($ "8"($)"$7e re!rre)"$ Jre"7"$K 7e

    +!&re'

    E)&($'$ )e!r&)$( e'#e,@"$ JNSEK

    T"#&' 7e )er C)er 7e #!(4) 7e (!($' #e!e$'/)e!r&

  • 7/25/2019 Expo Marcadires Tumorales (2)

    12/23

    (PRUEBAS DE MARCADORES TUMORALES TCNICASHISTOLGICAS)

    C4& 'e !'4 P$r$ $/!7$r e) e( 7"$8)4'+"& / e$(!$r ($ re'#!e'+$ $(

    +r$+$"e)+&

    F"

  • 7/25/2019 Expo Marcadires Tumorales (2)

    13/23

    (PRUEBAS DE MARCADORES TUMORALES TCNICASHISTOLGICAS)

    G&)$7&+r")$ &r"4)"$ >!$)$ WJBe+$->CGK

    T"#&' 7e )er C&r"&$r")&$/ +!&re' 7e (!($' 8er")$+"$'

    Te3"7& $)$("$7& Or")$ & '$)8re

    C4& 'e !'4 P$r$ e$(!$r e( e'+$7"& e( #r&)4'+"& / ($ re$"4) $(

    +r$+$"e)+&

    HE?

    T"#& 7e )erC)er 7e &$r"&

    Te3"7& $)$("$7& S$)8re

    C4& 'e !'4 P$r$ #($)"@"$r e( +r$+$"e)+& 7e( )er e$(!$r e( $$)e 7e ($

    e)@ere7$7 / "8"($r ($ re!rre)"$ Jre"7"$K

    HER2)e!$#("@"$"4) 7e( 8e) & '&

    Te3"7& $)$("$7& S$)8re / &r")$

    C4& 'e !'4 P$r$ $/!7$r $ 7"$8)&'+"$r ($ e)@ere7$7 e$(!$r ($ re$"4) $(

    +r$+$"e)+& /

    http://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000354453&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000046753&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000737142&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000445074&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000445074&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000044945&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000046092&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000445087&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000445087&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000046216&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000270742&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045793&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000044854&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000044854&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000354453&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000046753&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000737142&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000445074&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000044945&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000046092&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000445087&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000046216&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000270742&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045793&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000044854&version=Patient&language=Spanish
  • 7/25/2019 Expo Marcadires Tumorales (2)

    14/23

    (PRUEBAS DE MARCADORES TUMORALES TCNICASHISTOLGICAS)

    L$+$+& 7e'>"7r&8e)$'$

    T"#& 7e )er T!&re' 7e (!($' 8er")$+"$'

    Te3"7& $)$("$7& S$)8re

    C4& 'e !'4 P$r$ e$(!$r e( e'+$7"& e( #r&)4'+"& / ($ re$"4) $(

    +r$+$"e)+&

    L"8$)7& 1 7e !er+e #r&8r$$7$ JP=-L1K

    T"#& 7e )er C)er 7e #!(4) 7e (!($' )& #e!e$'

    Te3"7& $)$("$7& T!&r

    C4& 'e !'4 P$r$ 7e+er")$r '" e' $#r"$7& e( +r$+$"e)+& &) !) +"#&

    #$r+"!($r 7e +er$#"$ 7"r"8"7$

    *"r&8(&

    T"#&' 7e )er *e($)&$!+)e&/ )er &(&rre+$(

    Te3"7& $)$("$7& T!&r

    C4& 'e !'4 P$r$ 'e(e"&)$r $ #$"e)+e' ' #r&

  • 7/25/2019 Expo Marcadires Tumorales (2)

    15/23

    (PRUEBAS DE MARCADORES TUMORALES TCNICASHISTOLGICAS)

    *!+$"&)e' 7e (&' 8e)e'BRCA1/ BRCA2

    T"#& 7e )er C)er 7e &$r"&

    Te3"7& $)$("$7& S$)8re

    C4& 'e !'4 P$r$ 7e+er")$r '" e' $#r"$7& e( +r$+$"e)+& &) !) +"#&

    #$r+"!($r 7e +er$#"$ 7"r"8"7$

    Pr&+e,)$ 7e $+r" )!(e$r 22 JN*P22K

    T"#& 7e )er C)er 7e e3"8$

    Te3"7& $)$("$7& Or")$

    C4& 'e !'4 P$r$ "8"($r ($ re$"4) $( +r$+$"e)+&

    Ree#+&r 7e e'+r48e)&JERK / ree#+&r 7e#r&8e'+er&)$JPRK

    T"#& 7e )er C)er 7e 'e)&

    Te3"7& $)$("$7& T!&r

    C4& 'e !'4 P$r$ 7e+er")$r '" e( +r$+$"e)+& &) +er$#"$ >&r&)$(/

    $(8!)$' +er$#"$' 7"r"8"7$' e' $#r"$7&

    Se((& 7e 5#r&+e,)$'JO$1K

    T"#& 7e )er C)er 7e &$r"&'

    Te3"7& $)$("$7& S$)8re

    C4& 'e !'4 P$r$ e$(!$r ($ $'$ #("$ $)+e' 7e er$"4) #$r$ (& !e 'e

    '&'#e>$ 'er )er 7e &$r"&

    Se((& 7e 21 8e)e' JO)&+/#e =ZK

    GRUPO 7e re!#er$"4) D *ARCA=ORES TU*ORALES 15

    http://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045693&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000046047&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000046742&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000737140&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000046409&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045158&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000046367&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000046092&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000046092&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045693&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000046047&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000046742&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000737140&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000046409&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000045158&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000046367&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000046092&version=Patient&language=Spanish
  • 7/25/2019 Expo Marcadires Tumorales (2)

    16/23

    (PRUEBAS DE MARCADORES TUMORALES TCNICASHISTOLGICAS)

    T"#& 7e )er C)er 7e 'e)&

    Te3"7& $)$("$7& T!&r

    C4& 'e !'4 P$r$ e$(!$r e( r"e'8& 7e re!rre)"$ Jre"7"$K

    Se((& 7e ;0 8e)e' J*$$#r")+K

    T"#& 7e )er C)er 7e 'e)&

    Te3"7& $)$("$7& T!&r

    C4& 'e !'4 P$r$ e$(!$r e( r"e'8& 7e re!rre)"$ Jre"7"$K

    T"r&8(&e#$+"+"' "r$(e' "rr&'"' >e#+"$

    e)@ere7$7 ")@($$+&r"$ ")+e'+")$( #&("#&'"'.

    CEA

    T"#& 7e )er C)er &(&rre+$( 7e e'+4$8& #!(4) $$ / &$r"& +!&r

    #$)re+"&e3"8$ er" /e)7&e+r"&.

    GRUPO 7e re!#er$"4) D *ARCA=ORES TU*ORALES 16

    http://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000737131&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000044556&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000445091&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000737131&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000044556&version=Patient&language=Spanishhttp://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000445091&version=Patient&language=Spanish
  • 7/25/2019 Expo Marcadires Tumorales (2)

    17/23

    (PRUEBAS DE MARCADORES TUMORALES TCNICASHISTOLGICAS)

    Te3"7& $)$("$7& S$)8re

    C4& 'e !'4 P$r$ e$(!$r ($ e@e+""7$7 /$ !e #!e7e 'er #&& e'#e,@"& #&r

    e'& 7e

  • 7/25/2019 Expo Marcadires Tumorales (2)

    18/23

    (PRUEBAS DE MARCADORES TUMORALES TCNICASHISTOLGICAS)

    C$r$+er,'+"$' Se e(e$ e) e)@ere7$7e'

  • 7/25/2019 Expo Marcadires Tumorales (2)

    19/23

    (PRUEBAS DE MARCADORES TUMORALES TCNICASHISTOLGICAS)

    T"#& 7e )er )e!r&e)7&r")&' J)er "r&,+"& 7e #!(4) )e!r&e#+"$'.

    GAFP: una proteina que predomina en los astrocitos y que se considera como

    marcador especfico de los astrocitos en el SNC pero que tambin est presente

    en las clulas de Schwann no mielinizantes del sistema nervioso perifrico. osniveles de !"#$ aumentan notablemente durante la %liosis reactiva& cuando los

    astrocitos e'perimentan hipertrofia e hiperplasia

    GRUPO 7e re!#er$"4) D *ARCA=ORES TU*ORALES 19

  • 7/25/2019 Expo Marcadires Tumorales (2)

    20/23

    (PRUEBAS DE MARCADORES TUMORALES TCNICASHISTOLGICAS)

    Receptores a progesterona:la positividad a los receptores a la pro%esterona

    en los cnceres de mama u ovario permite asi%nar un tratamiento

    GRUPO 7e re!#er$"4) D *ARCA=ORES TU*ORALES 20

  • 7/25/2019 Expo Marcadires Tumorales (2)

    21/23

    (PRUEBAS DE MARCADORES TUMORALES TCNICASHISTOLGICAS)

    Receptores estrognicos:la positividad a los receptores estro%nicos de los

    cnceres de mama permite una pauta de tratamiento. (s un si%no para un buen

    pron)stico

    Sinaptofisina:una protena que forma parte de la membrana de las vesculas

    sinpticas. (l anticuerpo obtenido del suero de cone*o reacciona con las clulas

    neuroendocrinas de la mdula adrenal humana& la piel& tiroides& pulmones&

    pncreas y mucosa %astrointestinal mucosa. (ste anticuerpo identifica clulas

    neuroendocrinas normales y tumores neuroendocrinos

    GRUPO 7e re!#er$"4) D *ARCA=ORES TU*ORALES 21

  • 7/25/2019 Expo Marcadires Tumorales (2)

    22/23

    (PRUEBAS DE MARCADORES TUMORALES TCNICASHISTOLGICAS)

    TU*ORES SEOS =E PARTES BLAN=AS =EL SISTE*A*USCULOESMUELTICO.S4(& 'e #!e7e 7"$8)&'+"$r (& !e 'e '&'#e>$... S4(& 'e '&'#e>$ (& !e !)& &)&e &$( e)&' '$

  • 7/25/2019 Expo Marcadires Tumorales (2)

    23/23

    (PRUEBAS DE MARCADORES TUMORALES TCNICASHISTOLGICAS)

    CONCLUSIONES

    P$r$ (&' 7"@ere)+e' +"#&' 7e )er e"'+e)+e' >$/ !) $r$7&r e( !$( @$"("+$

    '! )&